m⁴ stands for...

...the joint biotech initiative in Greater Munich that pools the strengths of the hospitals and scientific institutes, the biotech and pharmaceutical companies and the cluster management company BioM.

4th Munich Biomarker Conference
November, 25th-26th, 2014
Submit your presentation or poster proposal now!
» more

  • » 23.10.2014
    4th Munich Biomarker Conference
    The interdisciplinary programme of the European Networking Event for Personalized Medicine on November 25th-26th, 2014... » more
  • Marlies Sproll, CSO of MorphoSys » 23.10.2014
    MorphoSys has now 3 antibodies in phase-3 - with pharma partners
    Roche, Novartis and now Janssen are the 3 big pharma, whose partnering programmes with a specific MOR antibody have... » more
  • » 15.10.2014
    Made in Munich: Amgen heading for "Bite" approval
    The American biotech giant Amgen has submitted an application to the immunomolecule blinatumomab, a bispecific... » more
  • » 14.10.2014
    NIH/DOD Non-Dilutive Funding Opportunities
    The seminar on December 4th informs about funding opportunities in the US. Currently, the National Institutes of Health... » more
  • » 13.10.2014
    IDBS Munich Best Practices R&D Forum
    The forum on November 20th has the undertitle "From endless paper to high productivity". R&D is a highly... » more
  • » 01.10.2014
    4th Munich Biomarker Conference - early bird discount
    Until October 10th, the 4th Munich Biomarker Conference on November 25th-26th, 2014 offers you an attractive early bird... » more